Skip to content

Apotheek Baeskens: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Apotheek Baeskens

BE 0477.868.124
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€10,947
2024 · €19,132-€8,185
Equity
€372,183
2024 · €361,236+€10,947
Cash
€94,603
2024 · €95,504-€901
Balance sheet total
€413,989
2024 · €426,768-€12,779

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets -€10,098

    down €10,098 (-24.1%), from €41,957 to €31,858

    of which Land and buildings: -€9,181

  • Receivables within one year -€6,183

    down €6,183 (-3.0%), from €204,288 to €198,105

    of which Other amounts receivable: -€13,547

  • Deferred charges and accrued income +€4,952

    up €4,952 (+230%), from €2,155 to €7,107

Equity and liabilities
  • Trade debts -€21,247

    down €21,247 (-40.3%), from €52,725 to €31,478

  • Reserves +€10,947

    up €10,947 (+3.2%), from €342,636 to €353,583

Income statement
  • Gross operating margin -€9,461

    down €9,461 (-23.9%), from €39,540 to €30,079

  • Taxes -€2,487

    down €2,487 (-36.9%), from €6,734 to €4,248

  • Other operating charges +€1,054

    up €1,054 (+93.8%), from €1,123 to €2,176

  • Financial income -€483

    down €483 (-55.2%), from €874 to €391

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €19,132
Gross operating margin -€9,461
Depreciation -€21
Other operating charges -€1,054
Other operating items +€22
Financial income -€483
Financial charges +€324
Taxes +€2,487
Result 2025 €10,947
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€372
Investment -€1,273
Financing €0
Cash 2024 €95,504
Net result for the year +€10,947
Depreciation +€11,371
Stocks and contracts +€549
Receivables within one year +€6,183
Deferred charges and accrued income -€4,952
Trade debts -€21,247
Tax, wage and social debts +€1,325
Other debts -€3,107
Accrued charges and deferred income -€697
Investment in fixed assets (net) -€1,273
Cash 2025 €94,603
brings cash intakes cash out
Every line side by side 40 lines
Line Code 2024 2025 Change %
Total assets 20/58 €426,768 €413,989 -€12,779 -3.0%
Fixed assets 21/28 €41,957 €31,858 -€10,098 -24.1%
Tangible fixed assets 22/27 €41,957 €31,858 -€10,098 -24.1%
Land and buildings 22 €37,255 €28,074 -€9,181 -24.6%
Plant, machinery and equipment 23 €709 €473 -€237 -33.3%
Furniture and vehicles 24 €3,992 €3,312 -€681 -17.1%
Current assets 29/58 €384,811 €382,130 -€2,681 -0.7%
Stocks and contracts in progress 3 €82,865 €82,316 -€549 -0.7%
Stocks 30/36 €82,865 €82,316 -€549 -0.7%
Amounts receivable within one year 40/41 €204,288 €198,105 -€6,183 -3.0%
Trade receivables 40 €29,726 €37,090 +€7,364 +24.8%
Other amounts receivable 41 €174,562 €161,015 -€13,547 -7.8%
Cash at bank and in hand 54/58 €95,504 €94,603 -€901 -0.9%
Deferred charges and accrued income 490/1 €2,155 €7,107 +€4,952 +230%
Total equity and liabilities 10/49 €426,768 €413,989 -€12,779 -3.0%
Equity 10/15 €361,236 €372,183 +€10,947 +3.0%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €342,636 €353,583 +€10,947 +3.2%
Distributable reserves 133 €342,636 €353,583 +€10,947 +3.2%
Amounts payable 17/49 €65,532 €41,806 -€23,726 -36.2%
Amounts payable within one year 42/48 €64,835 €41,806 -€23,029 -35.5%
Trade debts 44 €52,725 €31,478 -€21,247 -40.3%
Suppliers 440/4 €52,725 €31,478 -€21,247 -40.3%
Taxes, remuneration and social security 45 €1,389 €2,714 +€1,325 +95.4%
Taxes 450/3 €1,389 €2,714 +€1,325 +95.4%
Other amounts payable 47/48 €10,721 €7,615 -€3,107 -29.0%
Accrued charges and deferred income 492/3 €697 €0 -€697 -100%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €11,350 €11,371 +€21 +0.2%
Other operating charges 640/8 €1,123 €2,176 +€1,054 +93.8%
Non-recurring operating charges 66A €22 €0 -€22 -100%
Gross operating margin 9900 €39,540 €30,079 -€9,461 -23.9%
Operating profit (loss) 9901 €27,045 €16,532 -€10,513 -38.9%
Financial income 75/76B €874 €391 -€483 -55.2%
Recurring financial income 75 €874 €391 -€483 -55.2%
Financial charges 65/66B €2,052 €1,729 -€324 -15.8%
Recurring financial charges 65 €2,052 €1,729 -€324 -15.8%
Profit (loss) for the period before taxes 9903 €25,866 €15,194 -€10,672 -41.3%
Income taxes 67/77 €6,734 €4,248 -€2,487 -36.9%
Profit (loss) for the period 9904 €19,132 €10,947 -€8,185 -42.8%
Profit (loss) for the period to be appropriated 9905 €19,132 €10,947 -€8,185 -42.8%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 23 October 2026 via checked.be.